Abstract
Eighty four endophytic fungi were isolated from Ocimum sanctum. Secondary metabolites extracted from these endophytic fungi were tested for the inhibitors of enzymes responsible for the glycaemic index and polyol pathway. Six isolates were positive for both α-glucosidase and α-amylase inhibitors. Secondary metabolites from four endophytic fungal isolates inhibited aldose reductase enzyme extracted from rat lens. Crude extracts of fungal isolates POST075 and POST083 were found to be the most potent α-glucosidase inhibitors among the active isolates with IC50 values of 29.51 and 31.26 μg/mL respectively. Whereas, ethyl acetate extracts of fungal isolates POST034 and POST075 showed highest inhibition for pancreatic α-amylase enzyme in-vtiro with an IC50 value of 27.34 and 40.73 μg/mL respectively. The IC50 value for α-amylase enzyme inhibitors of POST034 and POST075 was very close to IC50 value of standard drug acarbose (25.7 μg/mL) tested under similar conditions. Crude extract of endophytic fungal isolate POST047 was found to be an effective aldose reductase inhibitor with an IC50 value of 29 μg/mL when compared to the IC50 value of standard drug quercetin that has an IC50 value of 15 μg/mL under similar condition. Fungal isolates with best inhibition activity were identified as Alternaria tenuissima (POST34), Trichoderma sp. (POST047), Diaporthe sp (POST075) and Colletotrichum gloesporioides (POST083) by the rDNA molecular method.
Keywords: Anti-diabetic, endophytic fungi, enzyme inhibitors, medicinal plant, molecular sequence.
Current Enzyme Inhibition
Title:In-vitro Studies on α-Amylase, α-Glucosidase and Aldose Reductase Inhibitors found in Endophytic Fungi Isolated from Ocimum sanctum
Volume: 10 Issue: 2
Author(s): Pavithra N., Sathish L., Suneel Kumar A., Venkatarathanamma V., Pushpalatha H., Bhanuprakash Reddy G. and Ananda Kulal
Affiliation:
Keywords: Anti-diabetic, endophytic fungi, enzyme inhibitors, medicinal plant, molecular sequence.
Abstract: Eighty four endophytic fungi were isolated from Ocimum sanctum. Secondary metabolites extracted from these endophytic fungi were tested for the inhibitors of enzymes responsible for the glycaemic index and polyol pathway. Six isolates were positive for both α-glucosidase and α-amylase inhibitors. Secondary metabolites from four endophytic fungal isolates inhibited aldose reductase enzyme extracted from rat lens. Crude extracts of fungal isolates POST075 and POST083 were found to be the most potent α-glucosidase inhibitors among the active isolates with IC50 values of 29.51 and 31.26 μg/mL respectively. Whereas, ethyl acetate extracts of fungal isolates POST034 and POST075 showed highest inhibition for pancreatic α-amylase enzyme in-vtiro with an IC50 value of 27.34 and 40.73 μg/mL respectively. The IC50 value for α-amylase enzyme inhibitors of POST034 and POST075 was very close to IC50 value of standard drug acarbose (25.7 μg/mL) tested under similar conditions. Crude extract of endophytic fungal isolate POST047 was found to be an effective aldose reductase inhibitor with an IC50 value of 29 μg/mL when compared to the IC50 value of standard drug quercetin that has an IC50 value of 15 μg/mL under similar condition. Fungal isolates with best inhibition activity were identified as Alternaria tenuissima (POST34), Trichoderma sp. (POST047), Diaporthe sp (POST075) and Colletotrichum gloesporioides (POST083) by the rDNA molecular method.
Export Options
About this article
Cite this article as:
N. Pavithra, L. Sathish, A. Kumar Suneel, V. Venkatarathanamma, H. Pushpalatha, G. Reddy Bhanuprakash and Kulal Ananda, In-vitro Studies on α-Amylase, α-Glucosidase and Aldose Reductase Inhibitors found in Endophytic Fungi Isolated from Ocimum sanctum, Current Enzyme Inhibition 2014; 10 (2) . https://dx.doi.org/10.2174/1573408011666141205233252
DOI https://dx.doi.org/10.2174/1573408011666141205233252 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiotonic Steroids in Adaptation to Dietary Salt Intake
Current Clinical Pharmacology Developing New Anti-Arrhythmics: Clues from the Molecular Basis of Cardiac Ryanodine Receptor (RyR2) Ca2+-Release Channel Dysfunction
Current Pharmaceutical Design Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)
Current Gene Therapy Regulation of the Cardiac Sodium/Bicarbonate Cotransporter by Angiotensin II: Potential Contribution to Structural, Ionic and Electrophysiological Myocardial Remodelling
Current Cardiology Reviews A Dietary Approach for Treating Dyslipidemia and Hyperglycemia
Current Nutrition & Food Science Is BMI Associated with COVID-19 Severity? A Retrospective Observational Study
Current Medicinal Chemistry Psychosocial Risk Factors Related to Ischemic Heart Disease in Women
Current Pharmaceutical Design Contrast-induced Nephropathy in Non-cardiac Vascular Procedures, A Narrative Review: Part 2
Current Vascular Pharmacology Mediterranean Diet and Low-grade Subclinical Inflammation: The Moli-sani Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Antimicrobial Peptides in Oral Cancer
Current Pharmaceutical Design Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies
Current Pharmaceutical Design In Vivo Monitoring of Cell Based Therapy in the Liver
Current Molecular Imaging (Discontinued) Quantification of Shear Stress and Geometric Risk Factors in Carotid Atherosclerosis: Review and Clinical Evidence
Recent Patents on Medical Imaging Low Density Lipoprotein Receptor-Related Proteins (LRPs), Alzheimers and Cognition
Current Drug Targets - CNS & Neurological Disorders From Laptop to Benchtop to Bedside: Structure-based Drug Design on Protein Targets
Current Pharmaceutical Design Mitochondrial Dynamics: An Emerging Paradigm in Ischemia-Reperfusion Injury
Current Pharmaceutical Design Pharmacological Therapy in Children with Nodal Reentry Tachycardia: When, How and How Long to Treat the Affected Patients
Current Pharmaceutical Design Multimodality Imaging for Interventional Cardiology
Current Pharmaceutical Design Sodium Tanshinone IIA Sulfonate Improves Adverse Ventricular Remodeling Post-MI by Reducing Myocardial Necrosis, Modulating Inflammation, and Promoting Angiogenesis
Current Pharmaceutical Design Understanding the Multifaceted Role of Inflammatory Mediators in Ischemic Stroke
Current Medicinal Chemistry